Cue Biopharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $14.7M | $32.2M | $22.5M |
| FY2025 | $15.8M | $42.2M | $27.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $14.7M | $32.2M | $22.5M |
| FY2025 | $15.8M | $42.2M | $27.1M |